Queen's Medical Center
Clinical trials sponsored by Queen's Medical Center, explained in plain language.
-
Hydroxychloroquine COVID-19 trial ends early with few participants
Disease control TerminatedThis study aimed to see if hydroxychloroquine, a malaria drug, could help hospitalized COVID-19 patients recover faster. It planned to enroll 350 adults but was stopped early with only 17 participants. The trial compared those who got the drug plus usual care to those who got usu…
Phase: PHASE3 • Sponsor: Queen's Medical Center • Aim: Disease control
Last updated May 17, 2026 03:57 UTC
-
COVID drug trial halted early: tocilizumab shows no clear benefit
Disease control TerminatedThis study tested whether the drug tocilizumab could help hospitalized adults with severe COVID-19. Participants received either the drug or a placebo, and their recovery was tracked for 28 days. The trial was stopped early after enrolling only 20 people, so the results are not c…
Phase: PHASE3 • Sponsor: Queen's Medical Center • Aim: Disease control
Last updated May 17, 2026 03:45 UTC